Jpmorgan Chase & CO Singular Genomics Systems, Inc. Transaction History

Jpmorgan Chase & CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Dec 26, 2024	BUY	$0.4 - $0.61 $15,526 - $23,677	38,815 New	38,815 $19,000
Q1 2024 May 10, 2024	SELL	$0.4 - $0.61 $5,188 - $7,912	-12,971 Reduced 25.05%	38,815 $19,000
Q4 2023 Dec 26, 2024	BUY	$0.33 - $0.58 $17,089 - $30,035	51,786 New	51,786 $23,000
Q4 2023 Feb 12, 2024	SELL	$0.33 - $0.58 $3,207 - $5,637	-9,719 Reduced 15.8%	51,786 $23,000
Q3 2023 Nov 14, 2023	SELL	$0.37 - $0.99 $5,830 - $15,601	-15,759 Reduced 20.4%	61,505 $23,000
Q2 2023 Aug 11, 2023	SELL	$0.78 - $1.28 $40,224 - $66,009	-51,570 Reduced 40.03%	77,264 $64,000
Q1 2023 May 18, 2023	BUY	$1.1 - $2.95 $47,570 - $127,575	43,246 Added 50.53%	128,834 $155,000
Q1 2023 May 11, 2023	SELL	$1.1 - $2.95 $6,517 - $17,478	-5,925 Reduced 6.47%	85,588 $103,000
Q4 2022 Feb 13, 2023	SELL	$1.82 - $2.71 $25,268 - $37,625	-13,884 Reduced 13.17%	91,513 $184,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.73 $60,895 - $115,213	-24,358 Reduced 18.77%	105,397 $264,000
Q2 2022 Aug 11, 2022	SELL	$2.86 - $6.44 $107,544 - $242,163	-37,603 Reduced 22.47%	129,755 $496,000
Q1 2022 May 11, 2022	SELL	$5.94 - $12.09 $3.83 Million - $7.79 Million	-644,604 Reduced 79.39%	167,358 $1.06 Million
Q4 2021 Feb 10, 2022	BUY	$10.45 - $16.9 $6.66 Million - $10.8 Million	637,752 Added 366.08%	811,962 $9.39 Million
Q3 2021 Nov 12, 2021	BUY	$10.9 - $27.63 $1.9 Million - $4.81 Million	174,210 New	174,210 $1.95 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.42B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.